Contact our breast care nurses
0808 800 6000
NHS England cancer waiting times data from October 2020 shows: The two week wait target for people referred with suspected breast cancer was...
The RxPONDER trial results were presented this year at the San Antonio Breast Cancer Symposium 2020. The study was investigating if some women with...
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “While this Plan to recover and redesign cancer services in Scotland...
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Today’s announcement includes funding for both the NHS and...
NHS England cancer waiting times data from September 2020 shows: The two week wait target for people referred with suspected breast cancer was...
Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said: While we’ve known for some time that HRT increases the risk of breast...
Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said, It’s is deeply concerning that 40% of charity-funded early career...
Mia Rosenblatt, Associate Director of Policy and Influencing at Breast Cancer Now, said: “We are very concerned that often there can be...
The Scottish Medicines Consortium (SMC) has today (9 November 2020) approved: Trastuzumab emtansine (Kadcyla) for routine NHS use in Scotland...
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
Sign up
Connect with us
